Naples, Italy

Pierosandro Tagliaferri

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,718 
Other
 patents

Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierosandro Tagliaferri: Innovator in Anti-Tumor Therapeutics

Introduction

Pierosandro Tagliaferri is a notable inventor based in Naples, Italy. He has made significant contributions to the field of medicine, particularly in the development of anti-tumor therapies. His innovative work focuses on the inhibition of specific microRNAs that play a crucial role in cancer progression.

Latest Patents

Tagliaferri holds a patent for "Inhibitors of miRNAs 221 and 222 for anti-tumor activity in multiple myeloma." This patent details the use of inhibitors targeting miRNAs 221 and 222, which are essential in the treatment of multiple myeloma. The inhibitors are characterized as LNA-miRNAs and have specific formulas that denote their structure and functionality. His patent represents a significant advancement in therapeutic strategies against this challenging form of cancer.

Career Highlights

Throughout his career, Tagliaferri has focused on innovative approaches to cancer treatment. His research has led to the development of novel therapeutic agents that aim to improve patient outcomes in multiple myeloma. His dedication to advancing medical science is evident in his work and the impact it has on the field.

Collaborations

Tagliaferri has collaborated with esteemed colleagues, including Pierfrancesco Tassone and Maria Teresa Di Martino. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of oncology.

Conclusion

Pierosandro Tagliaferri is a pioneering inventor whose work in anti-tumor therapeutics is making a significant impact in the fight against cancer. His innovative approaches and dedication to research continue to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…